Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02202213
What this trial is testing

Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 47
Testing effectiveness (Phase 2)UnknownNCT05753462
What this trial is testing

Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Sqy Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT04247594
What this trial is testing

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

Who this might be right for
Sickle Cell Disease
Pfizer 6
Early research (Phase 1)Study completedNCT01334073
What this trial is testing

Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors

Who this might be right for
Malignant Advanced Solid TumorsCarcinoma, Renal Cell
University Hospital, Bordeaux 19
Early research (Phase 1)Ended earlyNCT05162131
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers

Who this might be right for
Healthy
SFJ Pharmaceuticals, Inc. 34
Large-scale testing (Phase 3)UnknownNCT06444802
What this trial is testing

Model-informed Precision Dosing for Linezolid

Who this might be right for
Gram-Positive Bacterial Infections
University of Hamburg-Eppendorf 28
Testing effectiveness (Phase 2)Looking for participantsNCT05370820
What this trial is testing

Prevention of Postpartum Hemorrhage With Tranexamic Acid

Who this might be right for
Post Partum Hemorrhage
Inova Health Care Services 120
Testing effectiveness (Phase 2)Study completedNCT03020745
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects

Who this might be right for
Hepatitis B
GlaxoSmithKline 78
Not applicableNot Yet RecruitingNCT07494981
What this trial is testing

Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations

Who this might be right for
Ceftazidime-avibactam
Chinese PLA General Hospital 150
Early research (Phase 1)Study completedNCT06480981
What this trial is testing

Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers

Who this might be right for
Pharmacokinetics
DemeRx NB 55
Early research (Phase 1)Study completedNCT06727396
What this trial is testing

Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Who this might be right for
Healthy Subjects
Chong Kun Dang Pharmaceutical 44
Testing effectiveness (Phase 2)Study completedNCT04733040
What this trial is testing

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

Who this might be right for
GlomerulonephritisMembranous NephropathyantiPLA2R Positive
HI-Bio, A Biogen Company 24
Early research (Phase 1)Ended earlyNCT04855591
What this trial is testing

A Trial of SHR-1703 in Healthy Subjects

Who this might be right for
Asthma
Atridia Pty Ltd. 1
Early research (Phase 1)Study completedNCT00820417
What this trial is testing

Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib

Who this might be right for
Colorectal CancerHead and Neck CancerNon Small Cell Lung Cancer (NSCLC)
Harrison Clinical Research 63
Early research (Phase 1)Study completedNCT01416350
What this trial is testing

A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

Who this might be right for
Autoimmune Diseases
GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT04480697
What this trial is testing

Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects

Who this might be right for
Healthy
Hepagene (Shanghai) Co., Ltd. 56
Post-approval studies (Phase 4)Study completedNCT01466608
What this trial is testing

Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients

Who this might be right for
Hypercholesterolemia
Seoul National University Hospital 21
Early research (Phase 1)Study completedNCT00848510
What this trial is testing

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Who this might be right for
Colorectal and Ovarian Cancer Patients With Liver Metastases
Merck KGaA, Darmstadt, Germany 41
Early research (Phase 1)Looking for participantsNCT07672717
What this trial is testing

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

Who this might be right for
HIVProphylaxisInjectable
Johns Hopkins University 32
Early research (Phase 1)Not Yet RecruitingNCT07408908
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Xiamen Amoytop Biotech Co., Ltd. 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation